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The Health Research Board published the fi rst 
analysis of data from the National Drug-
Related Deaths Index (NDRDI) in November 
2008.1 The NDRDI is an epidemiological 
database which records cases of death by 
drug and alcohol poisoning and deaths 
among drug users and alcoholics. The 
NDRDI was established in September 2005 
to comply with Action 67 of the current 
National Drugs Strategy.2 The aim of this 
action was to put in place a system for 
recording drug-related deaths to enable the 
State to respond in a timely manner, with 
accurate data, on drug-related deaths and 
deaths among drug users. 
In order to ensure a complete and accurate 
database, the NDRDI records information 
from several different sources: the Coroner 
Service, the acute hospital sector through the Hospital In-Patient Enquiry scheme, the Central 
Treatment List (CTL) and the General Mortality Register. Only deaths which were either directly 
or indirectly attributable to drug use are included in the analysis presented in this fi rst NDRDI 
publication. 
Directly drug-related deaths (poisonings) are deaths in individuals directly due to the toxic effect 
of the consumption of a drug and/or other substance. Deaths arising from adverse reactions 
to prescribed medication are not included in the NDRDI. Indirectly drug-related deaths (non-
poisonings) are deaths in individuals with a history of drug dependency or non-dependent abuse 
of drugs (ascertained from toxicology results, CTL, medical or coronial records) whether or not the 
drug use was directly implicated in the death. 
Between 1998 and 2005, a total of 2,442 drug-related deaths were entered on the NDRDI 
database. Of these, 1,553 were poisonings and 889 were non-poisonings (Table 1). The annual 
number of deaths by poisoning increased from 242 in 1998 to 400 in 2005. 
Trends in drug-related deaths 
in Ireland
Table 1 Poisonings and non-poisonings by year of death, 1998 to 2005 (N = 2,442)
 1998 1999 2000 2001 2002 2003 2004 2005
242 271 261 276 336 296 360 400
Poisonings (n = 1553) 178 187 182 175 210 184 205 232
Non-poisonings (n = 889) 64 84 79 101 126 112 155 168
Two-thirds (1,047, 67%) of deaths by poisoning in the eight-year period were male and more than 
half were in people aged 20 to 40 years. Over half (839, 54.0%) were due to two or more drugs 
and/or substances. Opiates (heroin, methadone, analgesics containing an opiate compound, and 
other unspecifi ed opiates) were responsible for many of these deaths. Opiates accounted for 43% 
(305) of single-drug poisonings and were involved in 67.3% (565) of polysubstance poisonings. 
Cocaine, alone or in conjunction with another drug, was implicated in 100 deaths by poisoning 
over the period, an increase from fi ve in 1998 to 34 in 2005. 
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contents Drug-related deaths (continued) 
Prescription and over-the-counter medications 
were implicated in many of the deaths by 
poisoning. Benzodiazepines played a major role 
in polysubstance poisonings, and were involved 
in 30% of all deaths by poisoning. 
Overall, alcohol in conjunction with another 
drug or substance was involved in one-quarter 
(380, 24.5%) of all deaths by poisoning. This 
is an underestimation of the total number of 
alcohol-related deaths as cases of poisoning by 
alcohol alone are not included in this analysis. 
Since 2003, the annual number of deaths by 
poisoning outside Dublin has surpassed the 
number reported in Dublin (city and county), 
illustrating that drug use is now a nationwide 
issue.3
Calculating indirectly drug-related deaths 
allows, for the fi rst time, the illustration of the 
total burden of mortality related to drug use in 
Ireland. The number of deaths indirectly related 
to drug use increased over the period, from 
64 in 1998 to 168 in 2005. This may be an 
underestimation of the true fi gures, as details 
of drug using history are not always recorded 
in cases of death indirectly related to drug use. 
The number of non-poisoning deaths increased 
steadily over the reporting period both inside 
and outside Dublin.
The number of non-poisoning deaths refl ects 
the increasing numbers of people in the 
population who are consuming drugs, taking 
risks, developing dependencies, or who have 
developed other illnesses associated with 
drug use.
(Suzi Lyons, Ena Lynn and Simone Walsh)
This report may be downloaded from the 
publications section of the HRB website at 
www.hrb.ie. 
1. Lyons S, Lynn E, Walsh S and Long J (2008) 
Trends in drug-related deaths and deaths 
among drug users in Ireland, 1998 to 2005. 
HRB Trends Series 4. Dublin: HRB.
2. Department of Tourism Sport and Recreation 
(2001) Building on experience: National Drugs 
Strategy 2001–2008. Dublin: Stationery 
Offi ce.
3. National Advisory Committee on Drugs 
and Public Health Information and Research 
Branch (2008) Drug use in Ireland and 
Northern Ireland 2006/2007. Drug prevalence 
survey: Regional Drugs Task Force (Ireland) and 
Health and Social Services Board (Northern 
Ireland) results. Bulletin 2. Dublin: NACD.
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3On October 22 the Alcohol and Drug Research Unit of the 
Health Research Board (HRB) launched Crack cocaine in the 
Dublin region: an evidence base for a crack cocaine strategy 
on board the naval vessel the LE Eithne.1 The research was 
commissioned by the Intersectoral Crack Cocaine Strategy 
Group in response to a number of seizures of crack cocaine 
made by An Garda Síochána in the north inner city. 
The report indicates that the number of people using crack 
in Ireland remains low, with current users representing just 
1% of drug users who present for treatment and 0.1% of the 
general population. However, the report also makes the point 
that, despite targeted garda interventions, crack use has 
increased and availability has spread throughout the Dublin 
region. Launching the report, Minister of State John Curran 
TD said: ‘It is good news that the crack cocaine market 
has not taken hold in Ireland to the extent it has in other 
countries. However the report highlights the need to remain 
vigilant to ensure that this remains the case.’ The Minister 
also stated that the report will be central to the development 
of a timely strategic response through the new National 
Drugs Strategy which is being developed for 2009–2016. 
The HRB conducted the research over a nine-month period 
beginning in August 2007, using a rapid situation assessment 
technique developed by the World Health Organization. 
This involved a multi-method approach which brought 
together existing research and drug treatment and criminal 
justice data, supported by interviews with key informants 
such as drug users, gardaí, outreach workers and treatment 
specialists. 
The emergence of crack 
Crack cocaine is produced from powder cocaine using readily 
available chemicals such as ammonia and baking soda. A 
number of factors may explain the rise in crack cocaine use 
in Dublin. These include the increased availability of powder 
cocaine; the presence of problematic opiate users who have 
used crack cocaine in the UK or in Europe and have resumed 
crack consumption while living in Dublin; and the presence 
of non-Irish nationals who have access to cocaine supply 
routes and experience of preparing crack cocaine. 
Drug-using characteristics of crack users 
The majority of crack users used more than one drug, 
opiates (mainly heroin) were the most common drugs used 
alongside crack. Smoking was the predominant route of 
administration. A proportion of intravenous users made 
a transition from injecting powder cocaine to smoking 
crack cocaine because of the physical harms of injecting. 
Frequency of use ranged from daily to weekly and was largely 
dependent on available fi nancial resources. 
Dublin crack market 
The north inner city remains the primary crack market in 
Dublin. The market is dominated by non-Irish national 
dealers who import small amounts of cocaine via couriers. 
However, a growing number of Irish dealers are reported 
to be involved in the distribution of crack throughout 
the Dublin region, and prepared crack has been available 
throughout the city since 2006. Findings indicate that the 
crack market is a closed market, meaning that dealers do 
not sell to strangers, exchanges are generally arranged 
using mobile phones, and buyers are directed to exchange 
points outside the inner city. The price of crack is relatively 
stable and uniform, with prepared quantities or ‘rocks’ 
being sold for €50 or €100. Crack houses were reported as 
locations where crack was used and in some cases prepared 
in exchange for free crack; they were not reported as major 
venues for crack dealing or as sites for sex work. 
Social profi le and consequences of crack 
A high proportion of crack users are homeless, unemployed 
and do not have formal educational qualifi cations. According 
to data from treatment services, the majority of crack users 
were male and half were aged between 20 and 29 years. 
However, females involved in sex work and single mothers 
were reported to develop the most chaotic addiction. 
Common physical side effects of crack use are breathing 
problems, heart problems and rapid weight loss, and the 
most common psychological consequences are paranoia, 
aggressiveness and depression. Compulsive crack users 
reported neglecting their children, often diverting their 
fi nancial resources towards buying crack. Shoplifting, 
burglary and robbery were reported as common means for 
Crack cocaine in the Dublin region
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users to sustain their crack cocaine habit. Service providers 
also reported an increase in the numbers of women returning 
to or beginning sex work to fund their crack use. 
Intervention strategies
International evidence indicates that effective intervention 
strategies are those which combine attempts to disrupt 
local markets, making them less predictable to buyers and 
sellers, with attempts to divert drug offenders into treatment 
services. The most successful approaches to reducing or 
ceasing crack use are psychosocial interventions such as 
cognitive behavioural therapy. However, these interventions 
can only be successful if the user is attracted to and retained 
in treatment. 
A conference will take place on 24 February 2009 in Croke 
Park to further assess the fi ndings of this report, with a view 
to developing a strategic response involving key agencies 
and local communities. 
(Anne Marie Donovan and Johnny Connolly)
This report is available in the publications section of the HRB 
website at www.hrb.ie. For further information about the 
conference, contact jconnolly@hrb.ie.
1. Connolly J, Foran S, Donovan AM, Carew AM and Long J 
(2008) Crack cocaine in the Dublin region: an evidence base 
for a crack cocaine strategy. HRB Research Series 6. Dublin: 
Health Research Board.
Table 1 Lifetime, last-year and last-month prevalence of cocaine use (including crack) in Ireland, 2002/3 and 2006/7
Cocaine use Adults 
15-64 years
Males 
15 - 64 years
Females 
15-64 years
Young adults 
15-34 years
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
Lifetime 3.0 5.3 4.3 7.0 1.6 3.5 4.7 8.2
Last year 1.1 1.7 1.7 2.3 0.5 1.0 2.0 3.1
Last month 0.3 0.5 0.7 0.8 0.0 0.2 0.7 1.0
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2006, 2008)
Cocaine use in Ireland
Crack cocaine in Dublin (continued)
The fourth bulletin of results from the 2006/2007 all-
Ireland general population drug prevalence survey focuses 
on cocaine use in the adult population (15–64 years) 
and patterns of cocaine use.1 The Minister of State with 
responsibility for drugs strategy, Mr John Curran TD, 
launched the fi ndings for Ireland. The fi nal achieved sample 
was 4,967 in Ireland. This represented a response rate of 
65%. This article highlights some of those fi ndings and, in 
addition, presents unpublished data from the National Drug 
Treatment Reporting System (NDTRS) and the National 
Drug-Related Deaths Index (NDRDI).
Cocaine use increased in 2006/7 compared to 2002/3.2 
The proportion of adults who reported using cocaine 
(including crack) at some point in their lives increased from 
3% in 2002/3 to 5% in 2006/7 (Table 1). The proportion of 
young adults who reported using cocaine in their lifetime 
also increased, from 5% in 2002/3 to 8% in 2006/7. As 
expected, more men reported using cocaine in their lifetime 
than women, 7% compared to 3.5%. 
The proportion of adults who reported using cocaine in the 
last year (recent use) increased from 1% in 2002/3 to 2% 
in 2006/7 (Table 1). The proportion of young adults who 
reported using cocaine in the last year increased from 2% in 
2002/3 to 3% in 2006/7. 
The proportion of adults who reported using cocaine in the 
last month (current use) remained stable at under 1%.
Of the 4,967 survey respondents, 5% had used cocaine 
powder; crack cocaine use was rarely reported (0.6%). 
Half of all cocaine powder users commenced cocaine use 
before they were 22 years old, while half of all crack users 
commenced before they were 20 years old. 
Of the 25 current cocaine powder users, just over 68% used 
cocaine less than once per week, while 25% used it at least 
once per week. All of the current cocaine powder users 
reported snorting the drug. 
Of the 79 recent cocaine powder users, only 9% obtained 
their cocaine from a person who was not known to them. 
Cocaine powder was most commonly obtained at the home 
of a friend (43%) or at a disco, bar or club (36%). Almost 
two-thirds of recent cocaine powder users said that cocaine 
powder was easy to obtain within a 24-hour period. 
Of the 35 self-defi ned ‘regular’ cocaine powder users, almost 
82% had successfully stopped taking cocaine. The most 
common reasons for discontinuing were: concerns about its 
health effects (28%), could no longer afford it (17%), impact 
on employment, family and friends (11%), did not enjoy 
it any more (8.7%), attended a rehabilitation programme 
(8.2%) and did not want to continue using it (8.2%). 
The fi ndings of this survey should be interpreted with care in 
view of the small number of responses on which the patterns 
of cocaine use are based. The socially excluded population 
is unlikely to be represented in a general population survey 
of this kind; its members may not live at a fi xed address or, if 
listed, may be diffi cult to locate for interview. 
Analysis from the NDTRS indicates a sustained increase 
between 2001 and 2007 in the number of cases who 
entered treatment and reported cocaine as a problem drug. 
The number of treated cases reporting cocaine as a main 
problem drug increased considerably, from 81 in 2001 to 
770 in 2007 (Table 2), of whom 79% used one or more 
additional drugs. The number of cases reporting cocaine as 
an additional problem drug doubled from 624 in 2001 to 
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1,362 in 2007 (Table 3). When cocaine was reported as the 
main problem drug, cannabis, alcohol and ecstasy were the 
most common additional problem drugs, whereas when 
cocaine was reported as an additional problem drug the 
most common main problem drugs associated with its use 
were opiates and cannabis (Table 4). 
In 2007, of the 770 cases who reported cocaine as their 
main problem drug, 81% snorted it, 13% smoked it, and 4% 
injected it. Cocaine use by the same 770 cases in the month 
prior to treatment was reported as follows: 13% used it 
daily, 44% used it between two and six days per week, 11% 
used it once per week or less and 30% had not used it. Of 
note, no respondent participating in the NACD population-
based survey reported injecting cocaine, compared to 4% 
of the treated cases. As expected, the frequency of cocaine 
use among treated cases was considerably higher than that 
among the general survey population. 
In 2007, half of the treated cases for whom cocaine was the 
main problem drug had commenced its use before they 
were 20 years old, and 85% were men. In 2007, there were 
2,643 treated cases who reported cocaine as one of their 
problem drugs, of whom 1,107(41%) lived in the eastern 
region (Dublin, Kildare or Wicklow) and 1,536 (58%) lived 
elsewhere in Ireland. The demographic characteristics 
indicate that cocaine is available throughout Ireland. 
According to data from the National Drug-Related Deaths 
Index, the number of poisoning deaths in which cocaine was 
implicated, alone or with another drug, increased steadily 
from fi ve in 1998 to 34 in 2005.3 In that eight-year period, 
cocaine was involved in 100 (6.4%) deaths by poisoning. Of 
these, 29 (29.0%) were due to cocaine alone. Heroin and/
or methadone were often associated with cocaine in cases of 
polysubstance poisoning. 
Cocaine use in Ireland (continued)
Table 2 Cases entering treatment for cocaine as a main problem drug, 2001 to 2007
2001 2002 2003 2004 2005 2006 2007
 Number (%)
All cases entering treatment 4797 4948 5054 4506 4877 5191 5684
Cases reporting cocaine as 
main problem drug
81 
(1.7)
128 
(2.6) 
253 
(5.0)
331 
(7.3) 
467 
(9.6)
552 
(10.6)
770 
(13.5)
Of whom:
New cases 43 61 148 195 275 342 462
Previously treated cases 31 56 96 119 175 194 290
Treatment status not known 7 11 9 17 17 16 18
Source: Unpublished data from the NDTRS
Table 3 Cases entering treatment who reported cocaine as an additional problem drug, 2001 to 2007 
 2001 2002 2003 2004 2005 2006 2007
 Number (%)
All cases reporting an 
additional problem drug
 
3,459
 
3,582
 
3,760
 
3,157
 
3,401
 
3,692
 
3,816
Cases reporting cocaine as an 
additional problem drug
624 
(18.0)
829 
(23.1)
1095 
(29.1)
1029 
(32.6)
1144 
(33.6)
1362 
(36.9)
1368 
(35.8)
Of whom:
New cases 223 304 421 355 401 477 502
Previously treated cases 377 490 650 648 717 827 836
Treatment status not known 24 35 24 26 26 58 30
Source: Unpublished data from the NDTRS
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Cocaine use in Ireland (continued)
There are between 1.3 and 1.7 million problem opioid users 
in the EU and Norway, with heroin responsible for Europe’s 
largest drug-related health and social costs, according to 
the Annual report 2008: the state of the drugs problem in 
Europe, published by the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) in November.1 Data 
suggest that heroin use across Europe is stable but no longer 
diminishing. Some 12 million Europeans (15–64 years) have 
tried cocaine in their lifetime, compared with around 11 
million for amphetamines and 9.5 million for ecstasy. While 
the latest European data confi rm reports of a stabilising 
or even declining trend in the use of amphetamines and 
ecstasy, they point to a continued rise in cocaine use, albeit 
in a small number of countries. The Health Research Board 
(HRB) provides the Irish fi gures for the EMCDDA. 
Opioids
Ireland, like more than half of all EU countries, reported 
an increase in new opioid cases entering treatment since 
2005, with 1,032 new cases reported in 2007. Opioid use 
(principally of heroin) accounted for 63% of cases entering 
drug treatment in Ireland, compared to an average of 47% 
across Europe. In Ireland 9,769 cases received substitution 
treatment for opioid use in 2007. Figures from 2001 indicate 
that there are between 13,405 and 15,819 problem opiate 
users in Ireland. As in most other European countries, there 
was an increase in drug-related deaths in Ireland in 2004 and 
2005. The increase was largely due to an increase in opiate 
and cocaine-related deaths. There were 159 drug-induced 
deaths in Ireland in 2005, of which 88% were associated 
with opiate use. Research shows that the risk of overdose 
decreases substantially when heroin users are in substitution 
treatment. 
Table 4 Main problem drug and associated additional drugs used by new cases entering treatment, 2001 to 2007
(Jean Long)
1. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit (2008) Drug 
use in Ireland and Northern Ireland. 2006/2007 drug 
prevalence survey: cocaine results. Bulletin 4. Dublin: 
National Advisory Committee on Drugs.
2. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research 
Unit (2006) Drug use in Ireland and Northern Ireland. 
2002/2003 drug prevalence survey: cocaine results. 
Bulletin 4. Dublin: National Advisory Committee on 
Drugs.
3. Lyons S, Lynn E, Walsh S and Long J (2008) Trends in 
drug-related deaths and deaths among drug users in 
Ireland, 1998 to 2005. HRB Trends Series 4. Dublin: 
Health Research Board.
New cases 4,708 769 1,064 99 228 160 4,999
Main problem drug
Opiates Ecstasy Cocaine Amphet-
amines
Benzo-
diazepines
Volatile 
inhalants
Cannabis
Additional problem 
drug(s) used*
 
Number (%)
Opiates 751 
(16.0) †
16 
(2.1)
78 
(7.3)
1 
(1.0)
36 
(15.8)
2 
(1.3)
128 
(2.6)
Ecstasy 447 
(9.5)
394 
(37.0)
49 
(49.5)
32 
(14.0)
11 
(6.9)
1,897 
(37.9)
Cocaine 1,029 
(21.9)
206 
(26.8)
12 
(1.1)†
25 
(25.3)
37 
(16.2)
3 
(1.9)
865 
(17.3)
Amphetamines 89 
(1.9)
183 
(23.8)
109 
(10.2)
4 
(1.8)
2 
(1.3)
528 
(10.6)
Benzodiazepines 1,029 
(21.9)
20 
(2.6)
67 
(6.3)
2 
(2.0)
9 
(3.9)†
1 
(0.6)
117 
(2.3)
Volatile inhalants 17 
(0.4)
15 
(2.0)
5 
(0.5)
1 
(1.0)
3 
(1.3)
8 
(5.0)†
118 
(2.4)
Cannabis 1,866 
(39.6)
489 
(63.6)
611 
(57.4)
60 
(60.6)
56 
(24.6)
47 
(29.4)
6 
(0.1)†
Alcohol 466 
(9.9)
341 
(44.3)
497 
(46.7)
36 
(36.4)
103 
(45.2)
57 
(35.6)
2,389 
(47.8)
* By cases reporting use of one, two or three additional drugs 
† Additional problem drug(s) used may be a form of drug in the same family as the main problem drug. 
Source: Unpublished data from the NDTRS
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Around 3.5 million young Europeans (15–34 
years) have used cocaine in the last year, and 1.5 
million in the last month. In Ireland the proportion 
of young adults who reported using cocaine in 
the last year increased from 2% in 2002/3 to 3% 
in 2006/7. The European rate ranged between 
0.2% and 5.4%, placing Ireland among the high 
prevalence countries, such as the UK, Spain, 
Denmark and Italy, which have all seen a rise in 
the use of cocaine. Many EU countries report 
an increased demand for treatment for problem 
cocaine use. Data from Ireland’s National Drug 
Treatment Reporting System (NDTRS) show a 
considerable increase in cases reporting cocaine 
as a main problem drug, from 81 in 2001 to 770 
(of which 462 were new cases) in 2007. Some 500 
(12%) drug-induced deaths associated with cocaine 
use were reported to the EMCDDA for 2006; there 
were 34 (21%) such deaths in Ireland in 2005. As in 
many EU countries, the number of cocaine seizures 
in Ireland has increased with time, from 515 in 
2003 to 1,500 in 2006. 
Ecstasy and amphetamines 
The proportion of young adults in Ireland who 
reported using ecstasy in the last year remained 
relatively stable at 2.3% in 2002/3 and 2.4% in 
2006/7. The European rate ranged between 0.4% 
and 7.7%, placing Ireland among the medium 
prevalence countries. The number of treated cases 
who reported ecstasy as a main problem drug 
decreased considerably, from 219 in 2001 to 129 in 
2007. The number of deaths in which ecstasy was 
implicated, alone or in conjunction with another 
drug, averaged 10 a year between 2002 and 
2005. Amphetamine use is relatively uncommon in 
Ireland, with the percentage of adults who reported 
use in the last year remaining stable at 0.4% in 
2002/3 and 2006/7. 
Cannabis 
Cannabis use has not declined in Ireland, as it has 
in other parts of Europe, and remains the most 
commonly used illegal drug in this country. The 
proportion of adults who used it in the last year 
increased from 5% in 2002/3 to 6.3% in 2006/7, 
placing Ireland just below the EU average of 7%. 
While cannabis seizures account for the majority 
of all drugs seized in Ireland, the number of 
cases reporting cannabis as a main problem drug 
decreased steadily, from 1,370 in 2001 to 967 in 
2007, of which 16% were new cases, compared to 
the EU average of 21%. 
Vulnerable young people
While EU countries increasingly prioritise the risk of 
problem drug use to vulnerable young people, this 
political commitment is not matched by practical 
responses to reduce these risks. The existing 
responses favour offi ce-based or centre-based 
services over outreach work.
In Ireland young people vulnerable to drug use 
include children leaving state care and those in 
juvenile detention or special care facilities, early 
school leavers, homeless youth, people whose 
parents have a history of problem substance 
use, young people living in marginalised urban 
communities and, to some extent, Travellers. A 
number of Irish policy documents, including the 
National Development Plan, the Plan for Social 
Inclusion and the National Children’s Strategy, 
as well as the National Drugs Strategy, contain 
measures to help vulnerable young people 
through education, sport and recreation. Primary 
prevention measures are delivered through the 
school programmes Walk Tall and SPHE and the 
Young People’s Facilities and Services Fund (YPFSF). 
Arrest referral schemes provide information about 
appropriate services to young drug-using offenders 
and facilitate referral to treatment. 
(Brian Galvin)
1. The full report and all related media material 
are available on the EMCDDA website at www.
emcdda.europa.eu/events/2008/annual-report
2008 report on the drugs problem in Europe (continued)
The supply of heroin to Europe – 
update 
The European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) recently published a 
technical data sheet, Monitoring the supply of heroin 
to Europe.1 This review is based on the latest data 
and analysis available from specialised European 
and international organisations. 
The review states: ‘The sustainability of a general 
or improving situation in heroin use in Europe 
has been called into question by a series of record 
opium harvest in Afghanistan’ (p. 4). Although 
estimates suggest that the prevalence of opioid 
use has been relatively stable in recent years, rising 
numbers of both heroin seizures and heroin-related 
deaths indicate the likelihood of increased heroin 
availability in Europe. The review notes that there 
are a number of alternative explanations for this 
development, such as the success of enhanced 
and targeted law enforcement initiatives, the 
use of synthetic opioids, the concomitant use of 
opioids and other psychoactive substances, and 
the vulnerability of aging heroin users to sustained 
problematic use of the substance. 
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8Figure 1 General practitioners’ attitudes to methadone treatment, 2006
403020100 50 60 70 80 90 100
10.5 52.8 33.2 3.5Keep patients addicted to the substance 
It is difficult to get off methadone  
Daily supervision prevents patients from working
Reduces crime
Improves health of patient
Eliminates chance of double scripting
It is an overly rigid protocol
Essential service for drug users
Provides regular opportunity 
to monitor patients’ progress
Allows good relationship with patients
Percentage
Strongly agree Agree Disagree Strongly disagree
As demonstrated in the ROSIE study,1 methadone treatment 
reduces drug use, crime and death among opiate users in 
Ireland. Almost one-third (32%) of opiate users prescribed 
methadone substitution are cared for in private general 
practice. In light of this information, the Irish College of 
General Practitioners (ICGP) conducted a postal survey in 
2006 to determine the attitudes of GPs to the Methadone 
Treatment Protocol (MTP).2 
A questionnaire was sent to 600 GPs who were recorded on 
the ICGP’s drug misuse database as having received training 
in the management of methadone clients. Just under 35% 
(207) responded. It is notable that 247 GPs had patients on 
the Central Treatment List at the time of the study. 
Almost half of the GPs who responded were aged between 
46 and 60 years and 29% were female. Two of every three 
practices were situated in an urban area. Just over two-fi fths 
GPs’ attitudes to the Methadone 
Treatment Protocol
However, increasing availability is indicated by a substantial 
escalation in opium production in south-west central Asia, 
in Afghanistan in particular. In recent years, more than 
90% of the opium output detected worldwide has come 
from Afghanistan and it is estimated that the total 2007 
production of Afghan opium allowed the manufacture of 
733 tonnes of heroin. Afghan opium production doubled 
between 2005 and 2008 despite international eradication 
efforts. The continuing political instability of the region is 
considered a likely explanation for the growth in opium 
production (in tandem with very favourable weather 
conditions). The bulk of Afghan heroin destined for the 
Western European market is believed to travel through Iran 
and Turkey before entering various Balkan states, from where 
its is transported overland to the Netherlands and, to a lesser 
degree, to Belgium. 
This review highlights the continuing need to monitor the 
impact of the Afghan situation in Europe. In particular, 
‘answers are needed to questions of where opioids 
production is going; whether stockpiles are being 
constituted; whether there are signs of increased availability 
of heroin from Afghan origin in European consumer markets; 
whether the purity of heroin is being infl uenced; and 
whether consumer markets may be emerging or expanding 
along traffi cking routes and elsewhere’ (p. 17). 
(Anne Marie Donovan)
1. EMCDDA (2009) Monitoring the supply of heroin to 
Europe. EMCDDA technical data sheets. Luxembourg: 
Offi ce for Offi cial Publications of the European 
Communities. Available online at 
www.emcdda.europa.eu
The supply of heroin to Europe (continued)
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their practice area; the majority of these GPs practised in an 
urban location. Ninety-two per cent confi rmed that they had 
attended special training in methadone treatment.
Of the 207 GPs who completed the questionnaire, 72% 
were providing patients with methadone treatment at the 
time of the survey. Over half had 10 or fewer patients. Only 
35 prescribing doctors or their staff did not want any more 
patients. Forty-six GPs were willing to take more patients, 
which suggests that there is capacity that could be used to 
transfer additional suitable clients to a normal health care 
environment. 
The vast majority of GPs thought that the MTP was 
benefi cial to patients, though some said that methadone 
was addictive and diffi cult to get off (Figure 1). It was also 
noted that patients who attended daily might be prevented 
from working. 
Only 3% of GPs reported that their training was not 
suffi cient to stabilise patients receiving methadone 
substitution. One-third reported that their training was not 
suffi cient to manage the complications of drug use. Over 
two-fi fths reported that their training was not suffi cient 
to manage patients who continued to use illicit drugs. 
Just under two-thirds reported that their training was not 
suffi cient to manage patients with alcohol problems, while 
over half reported that their training was not suffi cient to 
manage patients with benzodiazepine problems. These 
responses point to issues that could be dealt with in future 
training programmes. 
The types of training that GPs considered most useful 
to them were small, locally based continuing education 
networks, individual mentoring, and distance learning. 
Consideration can be given to these preferences in the 
design of future training. 
The additional services most desired by GPs were addiction 
counselling, in-patient detoxifi cation and rehabilitation beds, 
and employment schemes 
(Jean Long)
1. Cox G, Comiskey C and Kelly P (2007). ROSIE Findings 4: 
summary of 1-year outcomes: methadone modality. Dublin: 
National Advisory Committee on Drugs. 
2. Delargy I (2008) Survey of general practitioners 
participating in the methadone treatment programme. 
Dublin: Irish College of General Practitioners. 
GPs attitudes to the MTP (continued)
Table 1 Total cases in methadone treatment, and number, treatment status and percentage of cases treated in 
 private general practice, 2002–2007 
Cases in methadone treatment 2002 2003 2004 2005 2006 2007
Total cases 7,419 7,736 8,800 9,354 9,675 9,769
Cases treated in general practice 2,323 2,494 2,699 2,827 2,890 3,161
Cases continuing in treatment in general 
practice from the previous year*
1,875 2,113 2,292 2,488 2,642 2,872
Cases entering treatment in general practice 
during the reporting year†
448 381 407 339 248 289
Cases treated in general practice as a 
percentage of total cases 
31% 32% 31% 30% 30% 32%
*Numbers obtained from the Central Treatment List 
†Numbers obtained from the National Drug Treatment Reporting System
Two national registers record drug treatment data in Ireland: 
the National Drug Treatment Reporting System (NDTRS) 
is an epidemiological database that records demand for 
treatment for problem alcohol and drug use, and the 
Central Treatment List (CTL) is an administrative database to 
regulate the dispensing of methadone treatment. 
The NDTRS is co-ordinated by staff at the Alcohol and Drug 
Research Unit (ADRU) of the Health Research Board (HRB) on 
behalf of the Department of Health and Children. 
The CTL was established following the Report of the 
Methadone Treatment Services Review Group 1998.1 This list is 
administered by the Drug Treatment Centre Board on behalf 
of the Health Service Executive and is a complete register of 
all patients receiving methadone as treatment for problem 
opiate use in Ireland.
According to these data sources, the total number of cases 
receiving methadone treatment increased by 32% between 
2002 and 2007 (Table 1). The number receiving treatment 
in private general practice increased by 36% during the 
same period. In each of the six years, at least 30% of cases 
who received methadone treatment were treated in private 
general practice. 
The proportion of cases continuing in methadone treatment 
each year was higher among those attending private general 
practice than among those attending other treatment 
providers (Table 2). The cases attending general practice 
were older than those attending other treatment providers. 
There was no difference in the gender profi le. 
GPs’ role in methadone treatment 
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The latest issue of European Addiction Research contains a paper 
on illicit methadone use and abuse in young people accessing 
treatment for opiate dependence in Ireland.1
At the time of publication, no research into methadone diversion 
had been conducted in Ireland. This study examines illicit use of 
methadone in a group of clients aged 25 and under attending 
a treatment programme for opiate dependence in the Drug 
Treatment Centre Board clinic in central Dublin in May 2005. 
Data were obtained through a structured interview covering 
demographic information, family background, treatment history, 
current and prior drug use, current and prior reasons for illicit 
methadone use, details of methadone supply, and experiences 
of selling methadone. 
Of the 81 people studied, the average age was 22 years, and 
51% were female. The average age of fi rst drug use was 13 
years, and 70% of participants reported cannabis as the fi rst 
illicit drug used. 
More than half of the participants (51%) reported that other 
family members had also used heroin. Thirty-one per cent of 
participants were homeless or living in a hostel. 
The average age of fi rst use of heroin was 15; one participant 
reported never having used heroin. The majority (91%) 
reported smoking as the fi rst route of administration of heroin, 
while the remaining 9% reported injecting as their fi rst route 
of administration. Almost four-fi fths (79%) reported having 
injected heroin at some point in their lives. 
The average prescribed daily methadone dose reported by 
participants was 66mg. Almost one-third (31%) reported that 
this dose did not control the symptoms of heroin withdrawal. 
More than half of participants reported the use of illicit 
methadone both prior to and during treatment. Counteraction 
of opiate withdrawal symptoms was the most common reason 
given. During treatment, failure to attend the clinic was the 
most common reason for withdrawal symptoms. Forty per cent 
obtained illicit methadone in order to do their own detox or 
maintenance. One-third reported using methadone for hedonic 
effects prior to commencing treatment. Participants reporting 
the misuse of benzodiazepines were more likely to report use of 
illicit methadone. 
Despite strict controls, 73% of participants reported that illicit 
methadone was easy to obtain. The most commonly listed 
marketplace was outside the treatment clinic, while other 
locations included the participants’ local areas, the quays, and 
outside city centre train stations. 
Of those buying methadone, 42% reported having a regular 
source. The majority of participants (82%) reported the supplier 
as someone on a methadone maintenance programme. The 
vast majority (93%) of participants who had received their 
methadone prescription as take-aways in the past reported 
being asked to sell it on; only 6% reported having done so. 
(Anne Marie Carew)
1. Roche A, McCabe S and Smyth BP (2008) Illicit methadone 
use and abuse in young people accessing treatment for 
opiate dependence. European Addiction Research, 14(4): 
219–225.
Illicit methadone use among young people
Table 2 Proportion of cases in methadone treatment in Ireland, by treatment status, gender and age group,   
 2002–2007
Treatment service
General practice Other
% %
Cases continuing in treatment from the previous year 87 75
Cases entering treatment (either new or returning) 13 25
Male 69 67
Female 31 32
Age group
10–14 years 0 0
15–19 years 1 2
20–24 years 13 18
25–29 years 31 32
30–34 years 24 24
35–39 years 15 13
40–44 years 9 7
45–49 years 5 3
50–54 years 2 1
55–59 years 1 0
60–64 years 0 0
65 years or over 0 0
(Jean Long, Anne Marie Carew and Vivion McGuire)
1. Methadone Treatment Services Review Group (1998) Report of the Methadone Treatment Services Review Group. Dublin: 
Department of Health and Children. Available as Appendix 4 in: Methadone Prescribing Implementation Committee 
(2005) Review of the Methadone Treatment Protocol. Dublin: Department of Health and Children. www.dohc.ie/
publications/methadone_review.html
GPs’ role in methadone treatment (continued)
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ROSIE study shows positive impact of 
opiate treatment 
On 9 October 2008 the 
NACD published a summary 
of opiate treatment outcomes 
at one year and at three years 
after entry to treatment.1 
At baseline, the 404 opiate 
users recruited to the study 
were entering treatment 
for the fi rst time, or were 
returning to treatment after 
a period of absence, at any 
one of 54 services nationwide. 
Of these, 289 individuals 
completed all three interviews 
– at baseline (2003/4), at one 
year (2004/5) and at three years (2006/7). These individuals 
(the per-protocol population) were asked the same questions 
at the three time points. The interview schedule examined 
key outcome measures, including:
drug use in the 90 days preceding the  ■
interview – specifi cally, type, frequency, quantity and 
cost;
measures of harmful practices and consequences; ■
health status, using a self-rated physical and psychosocial  ■
health assessment;
social functioning, including accommodation,  ■
employment, and involvement in crime; and
mortality, using information obtained from the  ■
participants’ contacts and the General Mortality Register. 
(Six of those who entered treatment died during the 
three-year period.)
The proportion of participants who reported using heroin 
in the 90 days preceding data collection fell from 81% at 
intake to 47% at one year, and was sustained at 47% at 
three years. The average frequency of heroin use in a 90-day 
period reduced from 42 out of 90 days at intake to 15 out 
of 90 days at one year but increased to 20 out of 90 days at 
three years. The average quantity of heroin consumed each 
day over a 90-day period decreased from 0.9 grams at intake 
to 0.3 grams at one year, and this lower consumption rate 
was sustained at three years. There was a corresponding 
reduction in the average amount spent on heroin on a 
typical day, from €75 at intake to €24 at one year; the 
average spend at three years was not reported. 
There were reductions in the proportions of participants 
who reported use of non-prescribed methadone, cocaine 
powder, crack cocaine, cannabis, alcohol and non-prescribed 
benzodiazepines at one year compared to the baseline 
interview. The reduced levels were maintained between 
one-year and three-year follow-up for all drugs except 
benzodiazepines.
Mr John Curran, Minister of State with responsibility for 
drugs strategy, attended an open day to celebrate the tenth 
anniversary of the Dun Laoghaire Rathdown Outreach 
Project (DROP) on 17 September 2008. The Minister talked 
to staff, service users and visitors about the importance 
of having community-based responses to addiction. He 
emphasised the need to support the families of those with 
addiction problems.
DROP provides a range of responses to meet the needs 
of individuals, families and communities who are affected 
by drugs and related issues. These include a three-year 
structured rehabilitation programme for drug users, one-
to-one supports for people who cannot yet commit to 
rehabilitation, an evening service for people using cocaine, 
and a facilitated drug-free support group. All of DROP’s 
services are client-centred, free and confi dential. DROP liaises 
with local agencies to support a continuum of care in areas 
such as parenting and housing supports, educational and 
skills development, work placements and training to support 
career progression. 
Through its own community employment scheme, DROP 
provides supported work placements with voluntary or 
community host agencies. DROP also hosts the local drugs 
task force’s education and development staff. 
(Brian Galvin)
For further information about DROP’s services, contact the 
Manager, Ruth McClaughry, on 01 280 3187 or by email at 
dropmanager@eircom.net
Minister attends tenth anniversary of 
DROP 
Minister John Curran and Edwina Kane, DROP 
receptionist, cut the cake at the DROP open day. The 
message on the cake reads ‘A Decade of Support’.
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The proportion of participants who reported use of more 
than one drug decreased from 78% at intake to 50% one 
year later and to 45% three years following intake.
The proportion of participants who reported injecting drug 
use in the 90 days preceding data collection decreased 
from 46% at intake to 29% at one year and 27% at three 
years. There was a small overall decrease in the proportion 
reporting an overdose, from 7% at intake to 4% at one year, 
to 5% at three years.
In relation to mental health symptoms experienced in the 
three months prior to each interview, there was no reduction 
at three years in the proportion who reported symptoms of 
anxiety and some reduction in the proportion who reported 
three of fi ve symptoms of depression. 
The proportion of participants living in unstable 
accommodation decreased from 25% at intake to 21% 
at one year and to 18% at three years. The proportion 
attending training courses in the six months prior to 
interview increased from 15% at intake to 29% at one 
year and to 33% at three years. In addition, the proportion 
currently employed increased from 15% at intake to 
20% at one year and to 31% at three years. The largest 
achievements between one and three years were in the areas 
of housing, training and employment. 
The proportion of participants who reported involvement in 
acquisitive crime decreased from 31% at intake to 14% at 
one year and this decrease was sustained at three years. In 
addition, the proportion who reported selling or supplying 
drugs reduced from 31% at intake to 11% at one year and 
this decrease was sustained at three years.
At the time of entry to treatment, 7% of the 289 participants 
were not using drugs; the proportion had improved to 
29% at one year and was sustained at 29% at three years. 
Of those for whom treatment status at three years was 
reported, 201 (70%) were still in treatment, of whom 173 
were in methadone treatment. 
(Jean Long)
1. Comiskey C, Kelly P and Stapleton R (2008) ROSIE 
Findings 7: Summary of outcomes for the per-protocol 
population. Dublin: National Advisory Committee on 
Drugs. 
Impact of opiate treatment (continued)
Frankfurt’s response to open drug 
scenes and drug-related harm
On the initiative of the Finnish Presidency of the EU in 2006, 
a European network of multi-agency partnerships tackling 
drug problems at front-line level was established in 2007. 
Called EXASS Net, the network is managed by the Pompidou 
Group of the Council of Europe.1 
The third EXASS Net meting was held in Frankfurt/Main, 
Germany, in May 2008. It began with the screening of a 
short fi lm on the city’s open drug scene in the 1980s and 
early 1990s. During those years, between 700 and 1,000 
injecting drug users were present in the city, day and night, 
making it one of the largest open drug scenes in Europe. An 
average of 16 injection-related medical emergencies a day 
required ambulance/doctor assistance and cost the city over 
€50,000 a week. Intensifi ed policing of the situation merely 
led to its displacement to other locations in the city. There 
were almost 6,000 drug users registered with the police at 
the time, with a hidden fi gure estimated at three to four 
times that number. The incidence of drug-related crime, 
particularly property offences, was high and the number of 
drug-related deaths reached nearly 150 a year. 
In the past 20 years, concerned stakeholders at frontline 
level (including law enforcement and social and health 
services) have been involved in a new approach to drug 
use in Frankfurt. Central to this new approach was the 
establishment of new partnerships between stakeholder 
agencies, called the Monday Round (1988) and the 
Friday Round (1989). The latter initiative initially involved 
consultation with street workers who were trying to 
cope with the open drug scene. Round-table partnership 
discussions started to provide solutions to the problems 
faced. The process involved:
building up crisis centres to attract those users who • 
were being moved on from the street;
an acknowledgement that the client group was high • 
demand and diffi cult;
the movement by police of out-of-town drug • 
users back to their own residential areas and the 
movement of Frankfurt drug users into crisis centres;
an emphasis on basic needs at the initial stage • 
of intervention, including accommodation and 
medical support, followed by diversion to treatment 
programmes as appropriate. 
There are currently 1,300 clients on methadone programmes 
in Frankfurt. Approximately 650 are treated in clinics, and 
the remainder in general practice. There is a range of low-
threshold services throughout the city dealing with different 
types of drug use and associated health and social problems. 
The fi rst drug consumption room, where drug users were 
provided with sterile injecting equipment and other services 
and where they could consume drugs under supervision, 
was opened in 1994. Crack-smoking facilities have been 
provided in consumption rooms since 2002. 
The fourth meeting of EXASS Net took place in Moscow in 
October 2008; future meetings are scheduled for Budapest, 
Oslo and Amsterdam. These meetings will consider subjects 
including youth drug cultures, party drugs and club scenes, 
the role of outreach in response to drug problems and the 
role of drug users in developing responses. 
(Johnny Connolly)
1. More information about the EXASS Network and online 
reports of its activities can be found at www.exass.net/
index.php.
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On 30 September the Dial to Stop Drug Dealing campaign 
was offi cially launched by Minister of State John Curran 
TD with the assistance of Superintendent Barry O’Brien of 
the Garda National Drug Unit (GNDU), Assistant Garda 
Commissioner Al McHugh and Mr Joe Doyle of the Health 
Service Executive (HSE). Individuals and communities 
affected by drug dealing were urged to pass on information 
relating to drug dealing in their local communities by 
dialling 1800 220 220. Individual names or numbers are 
neither requested nor recorded. Calls will be routed to call 
centres staffed by non-locals, separate from Garda barracks. 
All information will be passed on to An Garda Síochána. 
The campaign is being funded by the Dormant Accounts 
Fund, the Department of Community, Rural and Gaeltacht 
Affairs and the Department of Justice at a total cost of 
€450,000 for a three-phase campaign over nine months. 
Phase one will run from 1 November 2008 in communities 
in the areas of Tallaght LDTF, Blanchardstown LDTF, South 
West RDTF, North Inner City LDTF, and Dublin North East 
LDTF. In the second phase, to be rolled out in January 2009, 
the initiative will be promoted throughout the country. 
However, Minister Curran and Superintendent O’Brien 
strongly emphasised that, though the initiative will be 
promoted only within the Greater Dublin Area initially, 
all calls will be answered regardless of location and all 
information will be passed on to An Garda Síochána. Details 
of phase three have yet to be announced.
The project has already reported success in Blanchardstown 
LDTF where it was launched in 2006 as a part of the 
Blanchardstown LDTF’s supply reduction programme. 
After a successful six-week pilot phase, the campaign 
was extended. An evaluation of the Blanchardstown pilot 
initiative revealed that over 296 calls were received over the 
six-week period, over two-thirds of which were regarded 
as useful by An Garda Síochána.1 Assistant Commissioner 
McHugh commented that ‘court actions are pending 
because of the success of that campaign. This initiative 
is about getting at the big dealers who are targeting our 
young people and destroying communities. People can 
reclaim their communities by using this safe and confi dential 
mechanism to pass on their information.’ The Minister was 
also optimistic that the campaign would assist in promoting 
greater links between local communities and the gardaí. 
(Anne Marie Donovan)
1. Connolly J (2006) Blanchardstown Dial to Stop Drug 
Dealing campaign. Drugnet Ireland, (20): 17–18. See 
also Blanchardstown Local Drugs Task Force (2006) 
Blanchardstown Dial to Stop Drug Dealing: campaign 
evaluation executive summary report. Blanchardstown: 
BLDTF.
Dial to Stop Drug Dealing – launch of 
national campaign 
Ana Liffey Drug Project 
On 20 August 2008, the Ana Liffey Drug Project (ALDP) 
began operating an outreach programme in Dublin’s north 
inner city. This programme was developed in response 
to concerns raised about people with drug problems 
congregating on the Boardwalk along the north bank of 
the river Liffey.1 In addition, unpublished research by ALDP 
indicates that over 50% of individuals accessing ALDP 
services do so only once in any given month.1
The aim of the programme is for ALDP outreach staff to 
engage with people on the streets who are problem drug 
users and/or homeless. Outreach staff provide a variety of 
services with the objective of reducing the harm associated 
with drug use and/or homelessness. Services include: harm 
reduction and health promotion information; referrals to 
ALDP or other health and social care services; brief solution-
focused interventions; and promotion of the ALDP freephone 
number (1800 78 68 28) to encourage people to access 
ALDP services. Staff levels permitting, outreach is conducted 
every day.
The ALDP is in the process of developing a peer-led outreach 
service. Members of the ALDP peer group have created a 
leafl et with tips for staying safe on the street. The next step 
is for the peers to go on outreach together with ALDP staff. 
The peers will provide people who are problem drug users 
and/or homeless with information about keeping safe on 
the streets, and will advertise the ALDP peer group. The aim 
of this peer group is to provide harm reduction information 
and an opportunity for people to discuss any issues that are 
relevant to their lives. 
(Janet Robinson)
For further information about the ALDP, contact Marcus 
Keane on (01) 8786899 or marcus.keane@aldp.ie, or drop in 
to the service at 48 Middle Abbey Street, Dublin 1.
1. Keane M, ALDP, personal communication, October 2008. 
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National Registry of Deliberate Self 
Harm annual report 2006–2007 
The sixth annual report from the National Registry 
of Deliberate Self Harm was published in September 
2008.1 The report contains information relating 
to every presentation of deliberate self-harm to 
general hospital and paediatric hospital A&E 
departments in Ireland in 2006 and 2007, giving 
complete national coverage of hospital-treated 
deliberate self-harm. The Registry defi nes deliberate 
self-harm as ‘an act with non-fatal outcome in 
which an individual deliberately initiates a non-
habitual behaviour, that without intervention from 
others will cause self-harm, or deliberately ingests 
a substance in excess of the prescribed or generally 
recognised therapeutic dosage, and which is aimed 
at realising changes that the person desires via the 
actual or physical consequences’. 
According to the report there were 10,700 
presentations of deliberate self-harm, involving 
8,200 individuals, to hospital A&E departments in 
2006. There were 11,100 presentations by 8,600 
individuals in 2007, a rate 2% higher than in 2006. 
Reviewing data collected by the Registry for the 
six-year period 2002–2007, the report indicates 
that the rate of presentation of deliberate self-harm 
is relatively stable.
The national rate of deliberate self-harm in both 
2006 and 2007 was one-third (32% and 33%) 
higher among females than among males. 
Concordant with previous reports, deliberate 
self-harm was largely confi ned to the younger 
age groups. Almost half of all presentations (46% 
in 2006 and 47% in 2007) were by people aged 
under 30, and 88% were by people aged under 50. 
The peak age range for females presenting was 
15–19 years, at 600 per 100,000. This indicates 
that one in every 165 Irish adolescent girls was 
treated in hospital each reporting year as a result of 
deliberate self-harm. The peak age range for males 
presenting was 20–24 years, at 392 per 100,000.
Increased deprivation and social fragmentation 
were associated with increased rates of deliberate 
self-harm. Rates were higher in urban settings, with 
the highest rate reported in HSE Dublin/North East 
Region.
Repetition of deliberate self-harm accounted for 
almost one in four (23.1% in 2006 and 22.4% in 
2007) of all presentations, with men more at risk of 
repeated self-harm. 
Drug overdose was the most common form of 
deliberate self-harm, representing 74% of all such 
episodes reported in 2006–2007. Overdose rates 
were higher among females (80%) than among 
males (65%). On average, 31 tablets were taken 
in episodes of drug overdose. The total number of 
tablets taken was known in 78% of cases. Forty-two 
per cent of all drug overdoses involved a minor 
tranquilliser, 30% involved paracetamol-containing 
medicines and 22% involved anti-depressants/
mood stabilisers. According to the report, the 
withdrawal of the analgesic, Distalgesic, in January 
2005 has had a positive effect. Distalgesic was 
involved in approximately forty cases of self-harm 
in 2007 compared to approximately four hundred 
cases reported annually between 2002 and 2005. 
There was evidence of alcohol consumption in 41% 
of all episodes of deliberate self-harm, emphasising 
the strong association between alcohol 
consumption and suicidal behaviour. 
Self-cutting was the second most common method 
of deliberate self-harm, representing 21% of all 
episodes, and was more common among males 
than among females.
The emergency department was the only treatment 
setting for more than half (53%) of all deliberate 
self-harm patients, that is, they did not proceed to 
further treatment.
The report recommends the following measures to 
reduce the incidence of deliberate self-harm:
continued support of the national mental • 
health awareness campaign and related 
mental health promotion initiatives 
to reduce levels of psychiatric and 
psychological morbidity in the population;
additional resources to support mental • 
health promotion, and specialist mental 
health services for adolescents aged 15–19 
years;
evidence-based interventions targeting • 
people who repeatedly self-harm, with a 
focus on high risk groups;
restriction of the availability of minor • 
tranquillisers;
development of a mechanism for linking • 
data collected by the Registry with data on 
suicide mortality to improve understanding 
of the relationship between deliberate self-
harm and the risk of suicide in the future; 
and
extension of the core Registry dataset to • 
support evaluation of progress on actions 
in the strategy document on suicide 
prevention, Reach out,2 and increase our 
understanding of deliberate self-harm.
(Ena Lynn)
1. National Registry of Deliberate Self Harm 
Ireland (2008) Annual report 2006–2007. Cork: 
National Suicide Research Foundation. 
2. HSE, National Suicide Review Group and 
Department of Health and Children (2005) 
Reach out: national strategy for action on suicide 
prevention 2005–2014. Dublin: Health Service 
Executive
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Non-fatal overdose of known illicit 
drugs
Data used in the following analysis were extracted from 
the Hospital In-Patient Enquiry (HIPE) scheme. The 
Economic and Social Research Institute (ESRI) manages the 
HIPE scheme in Ireland. HIPE is a computer-based health 
information system designed to collect data on all discharges 
and deaths from acute general hospitals in Ireland. Each 
HIPE discharge record represents one episode of care; 
patients may be admitted to hospital(s) more than once 
with the same or different diagnoses. The records therefore 
facilitate analyses of hospital activity rather than of the 
incidence of disease. HIPE does not record information on 
cases that attend accident and emergency units but are not 
admitted as inpatients. In 2005 a new version (ICD-10-AM) 
of the International Classifi cation of Diseases codes used by 
HIPE was issued. Data pertaining to the year 2005 only are 
included in the following analysis.
There were 264 cases of overdose involving known illicit 
drugs1 in 2005. Six of these cases died, and are not included 
in this analysis. 
Age group and gender
Figure 1 shows that the 20–24-year age group is at highest 
risk, with the number of overdoses of known illicit drugs 
decreasing in older age groups. It is important to note the 
signifi cant number of cases in the 15–19-year age group. 
Males accounted for 80% (207) of cases. 
Figure 1 Number of cases of overdose of illicit drugs, by age group, 2005 
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Area of residence
More than one-quarter (26.4%, 68) of all overdose cases 
involving known illicit drugs were among persons resident in 
Dublin (city and county). Thirty-fi ve (13.6%) cases resided in 
Co Tipperary, a predominantly rural area. 
Poisoning intent
The poisoning was intentional in 37.6% (97) of cases. 
Accidental poisoning accounted for over one-quarter of 
cases (27.9%, 72), while the intent of the remaining cases 
was undetermined.
Illicit drugs most commonly used in overdose cases
There were 264 overdose cases involving known illicit 
drugs in 2005. In 16% (41) of these cases more than one 
known illicit drug was used. Hallucinogens were involved in 
38.4% (99) of cases, of which 15% had taken at least one 
other illicit drug. Opiates were involved in 29.5% (76) of 
cases; cocaine was involved in over a quarter (27.5%, 71); 
and cannabis was present in almost one-fi fth (19.4%, 50). 
Benzodiazepines were used in conjunction with a known 
illicit drug in 15% (39) of cases (Figure 2). 
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Needle and syringe exchange services were fi rst 
provided in Ireland in 1989, when fi ve exchanges were 
established. There are now 34 exchanges in the country, 
operating three models of service: fi xed-site exchanges, 
home visit exchanges, and exchanges in public locations. 
Peer-based, pharmacy, prison-based or vending machine 
exchange services are not available in Ireland.
This article presents a profi le of 31 needle and syringe 
exchange services operating between November 2007 
and February 2008. A service-inventory questionnaire was 
used to collect the data. The questionnaire comprised 
six sections: administrative details, profi le of target 
population, profi le of staff and volunteers working in 
the service, activities, management issues and new 
phenomena in relation to drug use.1 The 31 services 
provided exchanges at fi xed sites (28), on home visits 
(3) and in public locations (2); two services provided 
exchanges in two settings.
Of the exchanges surveyed, 17 were operated by 
government, 11 by a partnership of government and 
non-government organisations, and three by non-
government organisations. Two services provided social 
and medical care; six provided social care only and four 
provided medical care only. All provided services without 
charge to the client. 
Weekly opening times ranged from 24.75 hours over 
fi ve days in one service to one hour on one day in three 
services. Twenty of the services were open on one day 
a week for 1–2.5 hours. One service was open on seven 
days a week for one hour each day; this was the only 
service that operated a weekend provision. Eight of the 
services were open after 5 pm on one night a week. 
Of the 31 services, 20 provided services in urban 
locations, 12 in inner city locations and three in rural 
locations; some services operated in more than one 
location. The majority reported a dispersed open drug 
scene and/or a hidden scene in their areas. 
Seven of the services had no formal data-collection 
procedures, and two services were not open for all 
of 2007. A total of 22 services reported 7,069 client 
attendances in 2007. 
Overall, between 10% and 30% of clients were female. 
The youngest clients were aged between 16 and 20 
years. Twenty-fi ve services were open to any person aged 
over 18; fi ve of these also dealt with 16–18-year-olds. 
Two services catered for women and sex workers; two 
served residents only; and two operated specifi c services 
for ethnic minorities. Twenty-nine services reported that 
a signifi cant minority of their clients were homeless. 
Twenty-nine services reported heroin as the drug most 
commonly used by clients; 18 services reported cocaine 
as the most common. As expected, injecting was the 
most common route of administration (reported by 
Non-fatal overdose of illicit drugs (continued)
Figure 2 Types of known illicit drugs used in overdose cases, 2005 
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(Ena Lynn)
1. Only cases involving drugs that are known to be illicit 
are included. This analysis excludes opiates and other 
narcotics where provenance is unknown. 
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19 services). Benzodiazepine injecting was reported as 
a common practice by 11 services. Nineteen services 
reported that clients attending their service injected 
steroids. 
Thirty services reported that the outreach workers had 
an academic (but not a professional) qualifi cation. The 
remaining service reported that staff did not have formal 
qualifi cations. Thirty services were operated by two or 
more staff during a session; 15 had a general assistant 
present. Six services provided on-site access to health 
services, usually provided by a nurse; four provided on-
site access to counsellors. 
All 31 services reported that staff received training on the 
assessment of clients’ sexual risk practices and injecting 
practices, and on emergency responses such as overdose 
prevention techniques. Twenty-six services had a written 
document about staff training. 
A variety of policy and procedural documents have been 
developed to guide the operation of needle and syringe 
exchange services in Ireland. A written document for 
service providers in relation to health and safety issues was 
available in all services. A written document in relation to 
the health and safety of clients was available in 20 services. 
Thirty services offered staff vaccination against hepatitis A 
and B, and seven offered staff vaccination against tetanus.
All 31 services completed an assessment when a client 
accessed the service for the fi rst time. The majority of 
services recorded clients’ drug use, drug history and 
sexual health practices in the past year. The majority also 
recorded the blood-borne viral (BBV) infection status 
of their clients as well as their BBV test and treatment 
history. The amount of information recorded at the initial 
visit depended on 
how comfortable the client was in divulging this 
information. In some cases, service providers recorded 
basic client information (such as name, date of birth, 
drug of choice and mode of administration) at the initial 
visit and obtained additional details at subsequent visits. 
No service developed a written care plan for clients. 
However, 28 services reported reviewing clients’ needs 
after a number of visits – in some services after every two 
visits and in others after every 10 visits. 
The majority of services recorded the following data 
at each return visit: date, used injecting equipment 
returned, sterile equipment received, client’s sharing of 
injecting equipment (since last visit), drug(s) used (since 
last visit), condoms received, and length of visit. 
Information was recorded on client assessment forms 
in 30 services and on a computer system in 19 services; 
some services recorded the data in both ways. Of the 
services recording data on computer, 16 used the Drugs/
Aids Information System (DAIS), two used Microsoft Excel 
and one used a specially designed client-information 
system. 
Services provided a range of sterile injecting equipment 
and materials. All 31 services provided different sizes and 
types of needle and syringe, as well as alcohol swabs and 
citric or acetic acid. All services also provided condoms. 
Thirty services provided stericups or cookers and sterile 
water; 28 provided non-toxic foil (for smoking heroin); 
eleven provided syringe identifi ers; and seven provided 
tourniquets. No service provided single-use injecting 
packs, crack pipes or straws. 
All 31 services provided information on safer injecting 
practices, overdose prevention and blood-borne viruses; 
29 provided information on safer sexual health. All 
services discussed with clients the importance of safely 
disposing of needles and syringes.
All 31 services reported either providing social care and 
crisis counselling services on site or referring clients to 
other services that provided the necessary interventions. 
Accompanied referrals to either social care or health care 
services occurred infrequently in the majority of services. 
However, accompanied referrals to an emergency 
department were provided if a client presented to the 
service in a suicidal state. 
Some services provided facilities in addition to needle 
and syringe exchange: 11 had a drop-in, club, lounge 
or open-access service, of which fi ve had tea and coffee 
making facilities, nine provided meals (a sandwich at 
minimum), seven had leisure facilities (games, television), 
nine had telephone facilities and three had internet 
facilities available to service users. 
Day-bed facilities were not provided by any service, 
though two provided night-bed facilities, with 17 and 
20 beds available respectively. Lockers for personal 
belongings were available in two services. Eight services 
had personal hygiene facilities available to service users, 
of which seven had bath or shower facilities, seven 
had laundry facilities and four had clothes distribution 
facilities. 
(Janet Robinson, Sarah Gibney, Martin Keane and Jean 
Long)
The authors are grateful for the help of exchange service 
managers and outreach workers in preparing this article. 
1. Working Group on Data Collection within the 
Correlation Network (2008) Data collection protocol 
for specialist harm reduction agencies. Amsterdam: 
Foundation RegenboogAMOC.
Exchange services (continued)
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Responsible serving of alcohol 
(RSA) programmes evaluated
The geographical distribution of prisoners released 
in 2004 has been mapped to ‘set out what is 
known about the community contexts from which 
prisoners are drawn and to which they will likely 
return’.1 The research team, led by UCD Professor 
of Criminology Ian O’Donnell, used data from 
the Irish Prison Service’s new computer-based 
records system (PRIS) to track and map the known 
addresses of 5,057 prisoners (out of a possible 
5,588) who were released in 2004.
The method of mapping 
The known addresses of released prisoners were 
coded to the appropriate electoral division (ED) and 
these divisions were assigned a social deprivation 
rating according to a deprivation index.2 This 
index was computed using census data relating to 
unemployment, car ownership, overcrowding, local 
authority housing and social class. A further analytic 
dimension was provided by the calculation of a 
standardised prisoner ratio for each ED. This is the 
ratio of the observed number of prisoners in an ED 
to the expected number given the age and gender 
profi le of the ED population. 
Findings of the research
The most deprived areas in the country had 145.9 
prisoners per 10,000 population, compared to 
6.3 in the least deprived areas. The authors state 
that ‘the magnitude of this difference is startling 
and demonstrates unequivocally that it is the areas 
already marked by serious disadvantage that must 
The Heath Service Executive (HSE) recently 
published an evaluation of its responsible serving of 
alcohol (RSA) programmes – Club Cork and Smart 
Serve – in Cork city and its environs.1 
The Club Cork alcohol and drug awareness 
training programme is a partnership between 
signifi cant stakeholders involved in alcohol and 
drug awareness and health promotion in Cork city. 
This partnership comprises representatives of the 
health promotion department of HSE South, the 
Cork Local Drugs Task Force, the Garda Síochána, 
emergency departments, the emergency medical 
response team and a private security company. 
Club Cork is funded by the Cork Local Drugs Task 
Force. Initially devised to train nightclub staff to 
deal with alcohol- and drug-related issues on their 
premises, its remit has extended to training of 
personnel in pubs and clubs in Cork city. A total 
of 286 participants from nightclubs and pubs 
have been trained since its inception in 2003. The 
Smart Serve initiative was developed to promote 
responsible serving practices in off-licences; to 
date, approximately 60 personnel have completed 
this programme. 
A mixture of quantitative and qualitative methods 
was used to evaluate Club Cork and Smart Serve. 
Semi-structured interviews were conducted with 
representatives of licensed premises who had 
completed the training programme and with 
Club Cork organisers and trainers. In addition, a 
postal questionnaire was sent to 302 people who 
had done the RSA course; the response rate was 
a disappointing 10%, mainly explained by a high 
turnover in bar staff. Telephone and face-to-face 
interviews were conducted with off-licence 
staff who had participated in the Smart Serve 
training programme. 
The results indicate strong support for the Club 
Cork initiative. Its local partnership model was 
recognised as one of its main strengths. There was 
widespread support for RSA training becoming 
mandatory. The evaluation highlighted the need 
to explore the level of co-ordination between 
the Club Cork programme and other national 
RSA programmes, for example the Fáilte Ireland 
programme, to prevent unnecessary duplication. 
The evaluation noted that the future of the Smart 
Serve RSA programme for off-licences needed 
to be critically evaluated, given the existence of 
the National Off-Licence Association (NOffLA) 
Responsible Trading in the Community programme, 
which is compulsory for its members. The lack of 
participation by the major supermarket chains in 
RSA programmes was also noted as a major issue 
given the signifi cant volume of alcohol sales in 
these premises. 
It is hoped that the recommendations outlined in 
this report will contribute to the proposed further 
roll-out of training for management and staff of 
licensed premises, both locally and nationally. These 
initiatives are currently being developed to respond 
to local needs in Cork county and in Co Kerry with 
support from the Southern Regional Drugs Task 
Force.
(Deirdre Mongan)
1. Houghton F and Fitzmaurice E (2008) 
Responsible serving of alcohol: an evaluation 
of the Health Service Executive’s Club Cork and 
Smart Serve initiatives in the Cork region. Cork: 
HSE South. 
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bear the brunt of social problems that accompany 
released prisoners’ (p. 4). Most prisoners came from 
city areas – 28.6 per 10,000 population overall, 
compared to 6.3 from rural areas. Thirty-eight 
per cent of prisoners released in 2004 had Dublin 
addresses. A number of Dublin suburbs had high 
standard prisoner ratios for all crime sub-categories, 
including: Finglas, Ballymun and Darndale on the 
north side; Fettercairn and Jobstown in Tallaght; 
Cherry Orchard, Rowlagh, Moorfi eld, Palmerstown 
and Mulhuddart in the south west; Summerhill, 
Ballybough and Sherriff Street in the north inner 
city; and Dolphin’s Barn, the Coombe and the 
Liberties in the south inner city. Deprived suburban 
areas in Cork, Limerick and Galway also had higher 
prisoner ratios. However, a number of very deprived 
areas did not have any prisoners, particularly in 
Donegal, Kerry, Galway and Mayo.
Drugs and deprivation
This study clearly highlights the link between drugs 
and poverty: in the most deprived areas there were 
57.8 prisoners per 10,000 released after serving 
a sentence for a drug-related crime, compared 
to 1.8 in the least deprived areas. In terms of the 
geographic distribution of drug-related crime, 
Dublin, followed by the mid-west region (Clare, 
Limerick and North Tipperary) was more likely 
to have higher numbers of prisoners convicted 
for drug-related crimes. While the distribution 
of violent offenders in Dublin was spread evenly 
between the suburbs and the inner city, prisoners 
serving sentences for drug offences and, to a lesser 
degree, for property offences were more likely to 
emanate from the inner city than the suburbs.
Meeting the challenge of prisoner recidivism
The high rate of recidivism has been empirically 
demonstrated – more than 25% of offenders are 
re-incarcerated within 12 months of release and 
approximately 50% within four years.3 Mapping 
the areas that are likely to be home to returning 
prisoners pinpoints where the challenges are 
located; the next step is to target these areas 
with solutions. 
(Anne Marie Donovan)
1. O’Donnell I, Teljeur C, Hughes N, Baumer E 
and Kelly A (2007) When prisoners go home: 
punishment, social deprivation and the 
geography of reintegration. Irish Criminal Law 
Journal, 17(4): 3–9.
2. This index was calculated by the Small Area 
Health Research Unit (SAHRU) in Trinity College 
Dublin.
3. O’Donnell I, Baumer E and Hughes N 
(2008) Recidivism in the Republic of Ireland. 
Criminology and Criminal Justice, 8(2): 123–146.
Prisoner reintegration (continued)
An article in the Autumn 2007 issue of Drugnet 
Ireland described how illicit drug misuse has been 
fi tted into the new life cycle approach to social 
inclusion policy in Ireland, as presented in the social 
partnership agreement Towards 2016, the national 
development plan 2007–2013, and the action 
plan for social inclusion 2007–2016. The drugs 
issue is addressed within the childhood, youth and 
working age stages of the life cycle, and under the 
additional heading ‘Communities’.1 
On 1 October 2008 the Economic and Social 
Research Institute (ESRI) hosted an international 
seminar on the life cycle approach to social 
inclusion.2 The seminar marked the publication 
of the ESRI’s research into the role that life cycle 
factors play in shaping patterns of poverty and 
social exclusion in contemporary Irish society.3 The 
authors observed that the life cycle approach has 
been introduced in Ireland without any systematic 
effort to link its use to the broader literature on the 
concept, and no detailed consideration of how it 
should be applied in addressing social issues.4 
The authors explained how the life cycle approach 
to social inclusion marks a shift in perceptions 
of the nature of risk. Traditionally, social policy 
interventions have focused on risks associated 
with unemployment, disability, and insuffi cient 
resources in childhood and old age, and have 
tended to redistribute resources across the life 
cycle, from working age groups to children and 
to older people. More recently, social policy 
interventions have begun to focus on risks faced 
by specifi c sub-groups at particular stages in their 
lives, for example risks associated with entering 
the labour market, remaining in the labour market, 
or managing care responsibilities. These ‘new’ 
risk perceptions have emerged in response to the 
greater variability and reduced stability in career 
and family patterns. In essence, the life cycle 
approach seeks to reconcile social and economic 
objectives, and to emphasise the ‘multidimensional’ 
and ‘dynamic’ aspects of the social inclusion 
process: risks of being socially excluded are linked 
across problem areas, and diffi culties experienced in 
any specifi c life cycle stage may be a consequence 
of diffi culties in an earlier stage or a precursor of 
later problems.
The authors commented that while the life cycle 
approach offers a set of lenses through which to 
focus on the issues, it does not offer a ready-made 
set of prescriptions: a ‘general analytic framework 
that accounts for the dynamics and the links 
Applying the life cycle approach to 
social inclusion policy
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between events and the appropriate analytic tools’ 
is needed. To fully understand the nature of the 
dynamic inter-related risks requires the mapping 
of social exclusion patterns across the life cycle, 
and an understanding of the manner in which they 
combine with other socio-economic characteristics. 
Longitudinal data such as that beginning to emerge 
from the EU-SILC5 and being gathered through the 
Growing Up in Ireland (GUI)6 and the Longitudinal 
Study of Ageing in Ireland (TILDA)7 studies, are 
expected to greatly enhance Ireland’s capacity to 
map and analyse the dynamics and inter-related 
risks. These data will support research into the 
consequences of various policies and interventions 
for life cycle outcomes, and will play a critical role 
in translating the life cycle perspective into specifi c 
forms of policy evaluation and prescription. 
In the drugs area, longitudinal studies have been 
undertaken in Ireland that suggest how a ‘general 
analytic framework’ for a life cycle approach to the 
drug-related aspects of social inclusion policy might 
develop. For example: 
Irish children and their families: ■ 8 Conducted 
in two phases (1990 and 2000), this study 
investigated social development and family 
background, and health and well-being, 
and sought to assess childhood health and 
behaviour and the adult outcomes. Alcohol 
and drug use were two variables examined in 
this study.
Young people: ■ 9 Conducted in two phases 
(1998 and 2001), this ethnographic study of 
drug use among young people in a Dublin 
inner-city community analysed changes in 
drug use behaviour over the study period. The 
authors argued that models of risk that rely 
on individualistic and rationalistic assumptions 
struggle to accommodate the fl uidity and 
contradiction that characterises much drug use. 
Implications for strategies and initiatives aimed 
at reducing drug-related harm were discussed.
Research Outcome Study in Ireland (ROSIE): ■ 10 
This longitudinal drug treatment outcome 
study monitored the progress of opiate users 
entering treatment between September 2003 
and July 2004 at time-anchored points – at 
treatment intake, at one year and at three 
years after intake. The study monitored the 
infl uence of opiate treatment on key outcome 
measures, including drug use; general health; 
social functioning, including employment, 
accommodation and involvement in crime; 
harm (injecting behaviour and experience of 
overdose); and mortality. 
According to the authors of the ESRI research, it is 
these types of studies that will assist policy makers 
to recognise the varying needs of individuals and to 
design both services that provide protection against 
risks and also innovative social policy measures that 
address unmet needs and pre-empt problems. 
(Brigid Pike)
1. Pike B (2007) Where do illicit drugs fi t in the 
new social inclusion policy framework? Drugnet 
Ireland, (23): 5. 
2. Copies of the overhead presentations given at 
the seminar were retrieved on 17 November 
2008 at www.esri.ie 
3. Whelan CT and Maître B (2008) The life cycle 
perspective on social inclusion in Ireland: An 
analysis of EU-SILC. Dublin: Economic and Social 
Research Institute. 
4. Whelan CT and Maître B (2008) ‘New’ and 
‘old’ social risks: life cycle and social class 
perspectives on social exclusion in Ireland. 
Economic and Social Review, 39(2): 131–156. 
5. EU-SILC is an annual, EU-wide survey conducted 
in Ireland by the Central Statistics Offi ce, in 
order to obtain information on the income 
and living conditions of different types of 
households. It commenced in 2003.
6. Growing Up in Ireland is a government-
sponsored national study of children. 
Commenced in 2007, the study will take place 
over seven years and follow the progress of two 
groups of children; 8,500 nine-year-olds and 
10,000 nine-month-olds. The aim of the study 
is to paint a full picture of children in Ireland 
and how they are developing in the current 
social, economic and cultural environment.
7. The Irish Longitudinal Study of Ageing is a 
national study of a representative cohort of up 
to 10,000 Irish people over the age of 50 years. 
Commenced in 2006, the study will chart the 
health, social and economic circumstances of 
the participants over a 10-year period. 
8. Cleary A, Fitzgerald M and Nixon E (2004) From 
child to adult: a longitudinal study of Irish children 
and their families. Dublin: University College, 
Dublin.
9. Mayock P (2005) ‘Scripting’ risk: young people 
and the construction of drug journeys. Drugs: 
education, prevention and policy, 12(5): 349–
368. 
10. Further information on the ROSIE study, 
including the seven ROSIE Findings bulletins 
published to date, may be found on the website 
of the National Advisory Committee on Drugs 
at www.nacd.ie
Applying the life cycle approach (continued)
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In brief
Between 7 and 9 July 2008 the ‘Beyond 2008’ NGO Forum 
was held in Vienna. It was the fi nal step in the global 
consultation of NGOs involved in responding to drug-related 
problems. The Forum adopted by consensus a Declaration 
and three Resolutions. These have been submitted to the 
Commission on Narcotic Drugs and the United Nations 
Offi ce on Drugs and Crime for consideration as they prepare 
for the review of the UN’s 10-year (1998–2008) action plan 
against illicit drugs, which is due to take place in March 
2009. www.vngoc.org 
On 21 August 2008 the government’s new homelessness 
strategy, The way home: a strategy to address adult 
homelessness in Ireland, 2008–2013, was released by 
the Department of the Environment, Heritage and Local 
Government. www.environ.ie 
On 28 August 2008 the Institute of Public Health in 
Ireland and the Combat Poverty Agency published 
Tackling health inequalities: an all-Ireland approach to 
social determinants. The report highlights the extent to 
which health outcomes are infl uenced by social factors such 
as poor housing, nutrition and education. The report also 
demonstrates how health behaviours, e.g. the food we eat, 
how much exercise we take, whether or not we smoke or 
drink, have a direct and important impact on our health. 
The WHO estimates that lifestyle-related factors, including 
smoking and alcohol misuse, are implicated in at least a third 
of the total burden of disease in Europe. 
www.combatpoverty.ie / www.publichealth.ie 
On 26 September 2008 the British–Irish Council summit 
meeting agreed to a renewed focus on the families of 
problem drug users in any future drugs strategies prepared, 
with a view to providing increased support to those 
families and to better harness their potential to facilitate life 
improvements for problem drug users. 
www.british-irishcouncil.org 
On 30 September 2008 the Dial to Stop Drug Dealing 
campaign was launched. It includes a number of local 
and regional campaigns, organised through the local and 
regional drugs task forces. The objective is to encourage 
people to ring a confi dential telephone number with any 
information they may have on drug dealing. Details of the 
roll-out and operation of this national scheme were provided 
by Minister of State Curran in response to questions asked in 
Dáil Éireann on 7 October 2008. www.oireachtas.ie 
In September 2008 the Inspector of Prisons presented an 
interim report to the Minister for Justice, Equality and Law 
Reform. Reporting on his fi rst round of prison visits, the new 
Inspector reported a number of areas of particular concern, 
including the prevalence of drugs issues, an area in which he 
called for ‘positive action’ by prison management. 
www.justice.ie 
In September 2008 the National report for Ireland on 
strategies for social protection & social inclusion 2008–2010 
was submitted to the European Commission by the Offi ce 
for Social Inclusion. It sets out Ireland’s plans in response to 
the EU’s common objectives with regard to social inclusion, 
pensions and health and long-term care. The issue of illicit 
drugs is addressed under the heading of social inclusion. 
www.socialinclusion.ie 
On 2–4 October 2008, the European Society for Social 
Drug Research (ESSD) held its 19th annual conference 
in Budapest. Fifty researchers from 21 European countries 
presented some 36 current research projects for discussion 
with their colleagues about conceptual design and 
methodological issues. Irish researchers Paula Mayock, 
Jennifer Cronly and Michael Clatts presented a paper entitled 
‘The onset of heroin use among “high risk” youth in Ireland: 
an ethnoepidemiological approach’. (The Pompidou Group 
provides fi nancial support for the organisation of the ESSD 
annual conference and the publication of its annual book.) 
www.coe.int/t/dg3/pompidou 
On 7 October 2008 the role of sport and recreation in 
preventing drug use was the subject of a Parliamentary 
Question. Minister of State Curran responded: ‘While the 
provision of sport and recreational facilities may have a role 
to play, they will not, in themselves, provide the solution to 
the misuse of illicit substances. Ultimately, I believe that it is 
only through addressing the risk factors through both the 
National Drugs Strategy — and the broader social inclusion 
agenda — that we can ultimately reduce the prevalence of 
problem drug use in our society.’ www.oireachtas.ie 
On 14 October 2008 the budget for 2009 was announced 
by Brian Lenihan TD, Minister for Finance. In a statement 
on the same day Minister Ó Cuív and Minister of State 
Curran stated that their primary concern is to make every 
effort to ensure that the daily front-line services, especially 
those focused on the needs of the most socially deprived 
communities, are protected. With regard to drugs, the 
capital allocation of €8.1 million for 2009 includes 
funding for the Premises Initiative, which provides for the 
accommodation needs of community-based drugs projects, 
and also for the Regional Youth Initiative, announced earlier 
this year. This Initiative will provide capital funding for the 
development of dedicated youth facilities in regional drugs 
task force areas, not covered under the Young People’s 
Facilities and Services Fund. Sixteen projects are being 
supported under this Initiative to the tune of almost €2.3m. 
On the current side, the focus will be on protecting front-
line community-based projects and initiatives delivering vital 
services in areas worst affected by the drug problem. 
www.pobail.ie 
On 15–16 October 2008 the Children Acts Advisory 
Board’s 2008 National Conference was held in Dublin. The 
theme of the conference was ‘More than rhetoric: improving 
outcomes for children and their families through inter-
agency working’. www.srsb.ie 
In October 2008 the National Offi ce for the Prevention 
of Domestic, Sexual and Gender-based Violence (Cosc) 
published a summary of the submissions it had received 
with regard to the development of a national strategy on 
domestic, sexual and gender-based violence. Drugs were 
mentioned under two headings. With regard to ensuring 
that services meet the needs of various population groups, 
there was a call for the provision of high-dependency units 
for women who experience domestic violence and have 
alcohol and drug dependencies. With regard to legislative 
provisions, it was observed that the lack of a statutory 
defi nition of sexual consent gives rise to a lack of clarity, 
particularly in cases where capacity to give consent is in 
question, such as those involving people under the infl uence 
of drugs or alcohol. There were calls for an alternative, 
expanded and more comprehensive defi nition of the 
concept, with the principal focus being on the conduct 
of the accused rather than of the complainant. It was also 
stressed that the issue of consent and voluntary intoxication 
should be clarifi ed. www.cosc.ie 
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The Merchants Quay Ireland (MQI) annual 
review for 2007 was launched by Mr John Curran 
TD, Minister of State for drugs strategy on 12 
September 2008.1 
MQI’s needle-exchange service recorded that the 
number of client visits in 2007 remained steady at 
just under 40,000; however 1,333 of those visits 
were by new clients. The report also highlights 
a continuing high level of demand for homeless 
services, with an 11% increase in the number of 
meals provided for homeless people and a 33% 
increase in the numbers seeking help from MQI’s 
primary health care services 
The review describes the national prison-based 
addiction counselling service introduced in 2007 
and run by MQI in partnership with the Irish Prison 
Service. The service offers structured assessments 
and evidence-based counselling interventions 
with clearly defi ned treatment plans and goals. 
This occurs in the context of care planning within 
multidisciplinary teams. By December of 2007 MQI 
was providing 400 counselling hours per month 
within the prisons. When fully operational, the 
service will provide 1,000 counselling hours per 
month in 13 prisons nationally. 
The types of service offered by MQI and the 
numbers of people accessing them in 2007 are 
shown below. 
MQI annual review 2007 
Service Type of intervention No. of participants Outcomes
Needle-exchange 
and health-
promotion services
Promoting safer injecting 
techniques 
HIV and hepatitis prevention 
Safe sex advice 
Information on overdose
Not available 
 
(1,333 new clients) 
606 safer injecting 
workshops
Not available
Stabilisation services Methadone substitution 
Supportive day programmes 
Gateway programme 
Counselling
30 
17 
48 (monthly average) 
Not available
Not available 
Not available 
Not available 
Not available
Settlement service Assist service users to access 
interim and long-term 
accommodation
52 (monthly average) 36 people were 
successfully settled
Integration 
programmes
Access to transitional 
accommodation (Ballymount 
House) for up to 24 weeks 
Group and one-to-one 
therapeutic sessions
15 Not available
Training and work 
programmes
FÁS Community Employment 
scheme 
Catering training programme 
 
 
Catering training programme
130 
 
 
 
 
Not available
45% secured 
permanent 
employment or 
moved to further 
education 
Not available
High Park 17-week, drug-free residential 
programme including individual 
counselling, group therapy, 
educational groups, work 
assignments and recreational 
activities
52 (of whom 20 
were admitted for 
detoxifi cation)
16 completed detox 
St Francis Farm Therapeutic facility offering a 
6–12 month programme
54 17 completed three 
months or more
(Vivion McGuire)
1. Merchants Quay Ireland (2008) Annual review 
2007. Dublin: MQI.
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Drugs in prisons — healthcare is crucial
Article by Dagmar Hedrich in Drugnet Europe No. 64, 
October–December 2008
According to the [EMCDDA] Annual report 2008, survey 
data show that the EU prison population on a given day 
is over 600 000, with numbers of prisoners rising in most 
countries.1 It is estimated that, in almost all Member States, 
over 10 % of prisoners are drug-law offenders. And studies 
show that the proportion of inmates who have used heroin, 
cocaine or amphetamines in their lifetime can, in some 
prisons, be as high as 50–60 %. 
The fact that drugs fi nd their way into prisons, despite 
measures taken to reduce supply, is recognised by 
policymakers and prison experts alike. A challenge for 
prison systems in Europe is therefore to respond to the 
specifi c healthcare needs generated by drug problems, 
such as the burden of drug-related infectious diseases (e.g. 
hepatitis B and C, HIV/AIDS). According to the report, there 
are some indications that prison health policies are being 
shaped to meet these needs, with more countries than fi ve 
years ago now reporting prevention activities; infectious 
disease screening and vaccination; and treatment for drug 
dependence. 
But despite these improvements, much remains to be done. 
The report states that few prisons, for example, address the 
acute risk of death among newly released prisoners through 
overdose. Raising awareness of these risks and providing 
a seamless transition to external drug treatment, can play 
a key role in reducing drug-related deaths in this high-risk 
group.
1. Aebi MF and Delgrande N (2008) Council of Europe 
Annual Penal Statistics (SPACE 1): 2006 survey on prison 
populations. Strasbourg: Council of Europe Publishing.
National drug-related research in Europe
Cited from article by Margareta Nilson and Maria Moreira in 
Drugnet Europe No. 64, October–December 2008
Drug-related research is crucial to Europe’s understanding of 
its drug problems. Research enables Europe to learn lessons 
from the past, sharpens its awareness and monitoring of 
the present and helps countries prepare for the future. Yet 
building a picture of drug-related research in Europe remains 
challenging. 
National drug-related research in Europe, published by the 
EMCDDA on 17 October, aims to respond to this challenge.1 
The publication is based on reports compiled by 27 Reitox 
national focal points (NFPs) in 2007, which provide an 
outline of drug-related research at national level. Research 
was seen to have increased over the last decade in a number 
of areas, including: prevalence, incidence and patterns of 
drug use; the evaluation of interventions; and economic 
aspects. 
The report concludes that European drug-related research 
has seen considerable improvements since 1996. Research 
is now considered a priority in many EU Member States, 
being mentioned in the national drug policy documents 
of 20 of the 27 reporting countries. Also, most countries 
report relatively stable funding at national level, although 
concerns about funding availability and sustainability are still 
expressed. 
But despite some improvements, a number of issues 
remain unresolved. Well-functioning coordination among 
researchers, research centres and research areas, for 
example, continues to be a fundamental structural problem 
in most countries, as was the case in 1996. And, although 
most national drug strategies and action plans now refer 
to the need for evidence based policies, the link between 
research results and policymaking is often diffi cult to make. 
1. Available at www.emcdda.europa.eu/publications/
selected-issues. 
From Drugnet Europe
Drugnet Europe is the quarterly newsletter of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 
Drugs in focus is a series of policy briefi ngs published by the EMCDDA. Both publications are available at 
www.emcdda.europa.eu.
If you would like a hard copy of the current or future issues of either publication, please contact: 
Alcohol and Drug Research Unit, Health Research Board, Knockmaun House, 42–47 Lower Mount Street, Dublin 2. 
Tel: 01 2345 127; Email: adru@hrb.ie.
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Books
Drugs and 
popular culture: 
drugs, media 
and identity in 
contemporary 
society
Manning P (ed.) 
Willan Publishing 
2007, 290 pages 
ISBN: 978 1 
84392 210 0 
(paperback)
The use of illegal drugs is so common that 
a number of commentators now refer to 
the ‘normalisation’ of drug consumption. 
It is surprising, then, that to date very little 
academic work has explored drug use as 
part of contemporary popular culture. This 
collection of readings applies an innovatory, 
multi-disciplinary approach to this theme, 
combining some of the most recent 
research on ‘the normalisation thesis’ with 
fresh work on the relationship between 
drug use and popular culture.
The particular focus of the book is upon 
drug consumption as popular culture, and 
it offers new and important insights into 
the cultural signifi cance of widespread drug 
consumption as a feature of contemporary 
society. In drawing upon criminological, 
sociological and cultural studies 
approaches, this book makes an important 
contribution to the newly emerging fi eld 
positioned at the intersection of these 
disciplines. It provides an accessible 
collection of chapters and readings that 
explore drug use in popular culture in 
each of the main mass media, and in a 
way that is relevant to undergraduates and 
postgraduates studying a variety of courses, 
including criminology, sociology, media 
studies, health care and social work. 
Mortality 
amongst illicit 
drug users: 
epidemiology, 
causes and 
intervention
Darke S, 
Degenhardt L and 
Mattick R 
Cambridge 
University Press 
2007, 192 pages 
ISBN: 978 0 521 
85506 8 (hardback)
Over the past 40 years the rate of illicit drug 
use has risen dramatically, and with it the 
number o deaths reported among drug-
using populations. What are the clinical, 
ethical and psychopathological implications 
of these deaths? In this book, Shane Darke 
and his team provide the fi rst full, synthetic 
review of the epidemiology, causes, 
prevalence, demography, and associated 
risk factors of illicit-drug-related mortality. 
In addition, they examine and evaluate 
interventions to reduce these deaths. The 
major causes of death among illicit drug 
users are overdose, disease, suicide and 
trauma. Each is independently examined. 
This is an important book for all clinicians 
and policy-makers involved in issues relating 
to illicit drug use.
Journal articles
The following abstracts are cited from 
recently published articles relating to the 
drug situation in Ireland.
Illicit methadone use and abuse in young 
people accessing treatment for opiate 
dependence
Roche A, McCabe S and Smyth B 
European Addiction Research 2008; 14(4): 
219–225
Recent publications
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This study examines illicit methadone use 
in a group of young people attending 
a Dublin clinic for treatment of opiate 
dependence. A structured questionnaire 
was designed and administered to 
eligible participants (aged 25 years or 
under and receiving treatment for opiate 
dependence). Of the total number of 
participants (n = 81), 73% reported illicit 
methadone use before treatment entry and 
the main reason for use was to manage 
opiate withdrawals. During treatment 55% 
reported illicit methadone use and failure to 
get to the clinic was the main reason given. 
Some participants reported use for hedonic 
effects (33% prior to treatment and 12% 
in treatment). Despite strict controls, most 
participants reported that illicit methadone 
was readily available at low cost (EUR 
23 per 80 mg). Despite legislative and 
administrative efforts to curtail methadone 
diversion in Ireland, we found that it is 
widespread. Although it is generally used 
to self-medicate withdrawal symptoms in 
established opiate addicts, the extent of 
its use raises concerns as a risk for opiate 
overdose in the community.
An uncertain dominion: Irish psychiatry, 
methadone, and the treatment of opiate 
abuse
Saris AJ 
Culture, Medicine and Psychiatry 2008; 
32(2): 259–277
This paper investigates some productive 
ambiguities around the medical 
administration of methadone in the 
Republic of Ireland. The tensions 
surrounding methadone maintenance 
therapy (MMT) are outlined, as well as 
the sociohistorical context in which a 
serious heroin addiction problem in Ireland 
developed. Irish psychiatry intervened in 
this situation, during a time of institutional 
change, debates concerning the nature 
of addiction, moral panics concerning 
heroin addiction in Irish society and 
the recent boom in the Irish economy, 
known popularly as the Celtic Tiger. A 
particular history of this sort illuminates 
how technologies like MMT become 
cosmopolitan, settling into, while changing, 
local contexts.
Acute effects of cocaine on the 
neurobiology of cognitive control
Garavan H, Kaufman JN and Hester R 
Philosophical transactions of the Royal Society 
of London. Series B, Biological sciences. 2008; 
363(1507):3267–76
Compromised ability to exert control over 
drug urges and drug-seeking behaviour is 
a characteristic of addiction. One specifi c 
cognitive control function, impulse control, 
has been shown to be a risk factor for 
the development of substance problems 
and has been linked in animal models 
to increased drug administration and 
relapse. The authors present evidence 
of a direct effect of cocaine on the 
neurobiology underlying impulse control. 
In a laboratory test of motor response 
inhibition, an intravenous cocaine 
administration improved task performance 
in 13 cocaine users. This improvement 
was accompanied by increased activation 
in right dorsolateral and inferior frontal 
cortex, regions considered critical for 
this cognitive function. Similarly, for 
both inhibitory control and action 
monitoring processes, cocaine normalized 
activation levels in lateral and medial 
prefrontal regions previously reported to 
be hypoactive in users relative to drug-
naive controls. The acute amelioration of 
neurocognitive dysfunction may refl ect 
a chronic dysregulation of those brain 
regions and the cognitive processes they 
Recent publications (continued)
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subserve. Furthermore, the effects of 
cocaine on midline function suggest a 
dopaminergically mediated intersection 
between cocaine’s acute reinforcing effects 
and its effects on cognitive control.
Complications of heroin abuse
O’Connor G and McMahon G 
European Journal of Emergency Medicine 
2008; 15(2):104–6. 
A 21-year-old man presented to the 
emergency department in St James’s 
Hospital by ambulance. He was found 
collapsed at home by his uncle, 
complaining of severe pain and swelling to 
his left lower limb, with reduced sensation 
to his left foot. He was hepatitis C positive 
from intravenous drug use, and had most 
recently used both heroin and cocaine fi ve 
days previously on his release from prison. 
Musculoskeletal exam showed extensive 
swelling of his left lower limb, with tense 
calf compartments. Initial laboratory 
results showed a raised creatine kinase of 
more than 155,000 IU/l. Urine toxicology 
was positive for methadone, heroin 
and benzodiazepines, whereas urinary 
dipstick was positive for blood, which 
was confi rmed to be myoglobin by 
subsequent laboratory analysis. Atraumatic 
rhabdomyolysis is a syndrome characterised 
by injury to skeletal muscle with subsequent 
release of intracellular contents, that is, 
myoglobin and creatine kinase. Drugs have 
direct toxic effects, but may also cause 
coma-induced rhabdomyolysis, owing to 
unrelieved pressure on gravity-dependent 
body parts. Diagnosis is made with history 
(i.e. recent heroin or cocaine use), elevated 
serum CK, plus the possible presence of 
myoglobinuria. 
Aggressive i.v. rehydration remains the 
mainstay of treatment. If there is any 
evidence of compartment syndrome, 
urgent fasciotomy is required. Electrolyte 
imbalances should be corrected, unless very 
mildly abnormal. We have learned from our 
experience with this case that a high index 
of suspicion and thereby early recognition 
is crucial to prevent complications in 
intravenous drug users presenting with 
unusual symptoms and signs.
(Compiled by Louise Farragher and Joan 
Moore)
26
National Documentation Centre on 
Drug Use
TCD MSc students TCD Diploma students
Students from TCD’s MSc in drugs and alcohol policy and Diploma in addiction studies courses on recent 
visits to the National Documentation Centre on Drug Use (NDC). 
The NDC regularly hosts information sessions for groups of students. We also run day-long seminars 
comprising sessions on research-related topics and information literacy tutorials. If you are co-ordinator 
of a drugs or addiction programme and would like to arrange either a visit to the NDC or an external 
information session, please contact us at ndc@hrb.ie. 
Recent publications (continued)
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Upcoming events
(Compiled by Louise Farragher – lfarragher@hrb.ie)
January 
13 January 2009 
6th Annual Drug & Alcohol Professionals 
Conference
Venue: Royal Institute of British Architects, 
London 
Organised by/Contact: Federation of Drug & 
Alcohol Professionals (FDAP) and Drink & Drugs 
News 
Email: offi ce@fdap.org.uk 
www.fdap.org.uk
Information: This year’s plenary presentations 
will cover:
The new drug strategy and evaluation of • 
the fi rst drug strategy. 
Working with families. • 
Young drinkers and implications for • 
policy. 
Getting people into employment. • 
The Independent Safeguarding Authority • 
and implications for our fi eld. 
Diversity and inequality at work. • 
Practical workshops and seminars will cover a 
range of issues, including: khat, ketamine and 
cannabis; diversity and dual diagnosis; Suboxone 
(buprenorphine/naloxone); staff training and 
development.
January – March
Drugs & Alcohol at Work: Complying with 
Section 13 of the Safety Health & Welfare at 
Work Act 2005
Organised by/Contact: Anita Furlong, 
Conference Administrator, EAP Institute, 143 
Barrack Street, 
Waterford, Ireland 
Tel: +353 (0)51 855733 
Email: anita@eapinstitute.com 
www.eapinstitute.com
Thursday 22 January 2009
Venue: Viking Ramada Hotel, Waterford
Thursday 19 February 2009
Venue: Courtyard by Marriott Hotel, Galway
Thursday 12 March 2009
Venue: Carlton Hotel, Dublin Airport
Information: The purpose of these seminars is 
to outline the impact of drug impairment in the 
workforce, and practical steps in the recognition 
and treatment of employees whose behaviour 
presents risks to themselves and others while at 
work. Subjects covered will include:
Directors’ responsibilities, risk assessments • 
and control measures to comply with 
Section 13, Safety, Health and Welfare at 
Work Act 2005. 
Update on the development of workplace • 
policies, HAS regulations, codes of 
practice and employment law issues. 
Standard operating procedure (SOP) • 
and laboratory best practice for employee 
drug testing. 
February 
11 February 2009
Families, drugs and alcohol: innovations in 
practice, new insights from research
Venue: Cavendish Conference Centre, 22 
Duchess Mews, London 
Organised by/Contact: KCA (UK) Training and 
Professional Development, 43a Windmill Street, 
Gravesend, Kent, DA12 1BA 
Tel: +44 (0)1474 326168 
Email: tcw@kca.org.uk 
www.kca.org.uk
Information: Children, including the unborn, 
whose parents misuse alcohol and illicit drugs 
are at increased risk of developing substance 
misuse problems in later life, as well as being 
exposed to an assortment of other threats to 
their development. Specialised services targeting 
families have expanded rapidly in recent years, 
a trend that has been further accelerated by the 
new drug strategy. This conference will provide 
a timely opportunity for practitioners, service 
commissioners, policy makers and researchers 
to share good practice and new understandings 
from research.
March
11–14 March 2009
The 3rd International Conference on Fetal 
Alcohol Spectrum Disorder. Integrated Research, 
Policy and Promising Practice around the World: 
A Catalyst for Change
Venue: Victoria Conference Centre, British 
Columbia, Canada 
Organised by/Contact: University of British 
Columbia 
Tel: +1 (604) 822-7524 
E-mail: ipad@interchange.ubc.ca 
www.interprofessional.ubc.ca 
Information: The conference goal is to highlight 
international research and promising practice 
as a catalyst for promoting social inclusion and 
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creating healthy communities. Participants 
can expect to:
Learn about the current practical • 
application of leading research around 
the world and its potential to effect 
future change. 
Learn about ways to engage multiple • 
communities at multiple levels and 
build capacity. 
Promote and nurture linkages • 
across families, communities and 
international networks. 
Foster clinical and community-based • 
research. 
June
2–5 June 2009
12th European Federation of Therapeutic 
Communities Conference: Eyes on the future
Venue: World Forum Convention Center, 
The Hague 
Organised by/Contact: Brijder 
Verslavingszorg and Verslavingszorg Noord 
Nederland (VNN) 
Chair of Local Organising Committee: Mark 
de Haan 
www.eftc-bepartofthesolution.eu 
Information: The European Federation of 
Therapeutic Communities invites abstracts for 
this conference on Rehabilitation and Drug 
Policy. Further details on the EFTC website. 
The main conference themes are:
Effectiveness: evidence based and best • 
practice. 
Organisation and innovation. • 
Justice. • 
Population mobility and new • 
challenges in treatment and 
prevention. 
The growth and role of spirituality in • 
addiction treatments.
Upcoming events (continued)
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